Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-24T03:22:13.558Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

Published online by Cambridge University Press:  23 January 2017

J. Stone ,
I. Koychev ,
T. Reilly  and
P. McGuire
J. Stone*
Affiliation:
Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK
I. Koychev
Affiliation:
Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford OX3 7JX, UK
T. Reilly
Affiliation:
Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK
P. McGuire
Affiliation:
Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK
*
*Author for correspondence: J. Stone, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychological Medicine , Volume 47 , Issue 5 , April 2017 , pp. 983
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hallak, JE, Maia-de-Oliveira, JP, Abrao, J, Evora, PR, Zuardi, AW, Crippa, JA, Belmonte-de-Abreu, P, Baker, GB, Dursun, SM (2013). Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry 70, 668–676.CrossRefGoogle ScholarPubMed
Hartz, SM, Pato, CN, Medeiros, H, Cavazos-Rehg, P, Sobell, JL, Knowles, JA, Bierut, LJ, Pato, MT; Genomic Psychiatry Cohort Consortium (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 71, 248–254.Google Scholar
Maia-de-Oliveira, JP, Baker, GB, Dursun, SM, Hallak, JE (2016). Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained? Psychological Medicine. Published online 9 December 2016. doi:10.1017/S003329171600307X.Google Scholar
Stone, JM, Morrison, PD, Koychev, I, Gao, F, Reilly, TJ, Kolanko, M, Mohammadinasab, A, Kapur, S, McGuire, PK (2016). The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. Psychological Medicine 46, 3443–3450.Google Scholar